Overview of Electronic Prior Authorization (ePA) and Overcoming Barriers to Implementation
Webinar Recorded on June 18, 2014
Electronic prior authorization (ePA) represents a significant opportunity to enhance ePrescribing and Prior Authorization (PA) workflows, which directly benefit patients by identifying the most appropriate medications. AMCP believes that slow uptake of ePA adoption may lead to unnecessary PA mandates by state governments and avoidable time and costs associated with the current PA process.
Join us in collaboration with the National Council for Prescription Drug Programs (NCPDP)on Wednesday, June 18th at 2:00 pm EST to learn more about ePA and hear from the experts and lessons learned from early adopters. Electronic prescribing is experiencing unprecedented growth and the industry is on its way to building a solid data exchange infrastructure. Capitalizing on this trend, ePA is poised to evolve into an efficient way to maintain costs, improve administrative workflows and upgrade the quality of care. Today's prior authorization process of paper forms, faxes and phone calls is time-consuming and disruptive to clinical care. What impact does this have on healthcare costs and delivery of patient care? How and to what degree could this experience improve with market adoption of the NCPDP ePA standard? Learn why prescribers rate ePA as one of the most desired capabilities within their ePrescribing workflow. What are the workflow scenarios and how can other electronic information be leveraged as part of the ePrescribing workflow? Hear what doctors, pharmacies and PBMs have to say about their experience with the ePA pilot and what promises they see for the future.
- Tony Schueth, CEO & Managing Partner, Point-of-Care Partners, LLC
- Dr. Anita C. Murcko, MD, FACP, Cambiare, LLC
- Melissa Brown, Surescripts, LLC